Skip to content
E LENV10 mg

Drawing based on the label description. No photo yet.

E LENV 10 mg pill

Pill with imprint E LENV 10 mg is red & yellow, capsule, 14 mm and has been identified as Lenvatinib 10 mg. It is used for renal cell carcinoma and thyroid neoplasms. It is supplied by Eisai Inc.

Lenvatinib 10 mg

Imprint
E LENV 10 mg
Strength
10 mg
Used for
Renal cell carcinoma and thyroid neoplasms
Color
Red, Yellow
Shape
Capsule / oblong
Size
14 mm
Score
No score line
Form
Capsule
Manufacturer
Eisai Inc
Drug class
Cancer medicine (kinase inhibitor)
NDC
62856-710, 62856-710-05, 62856-710-30, 62856-714, 62856-714-05, 62856-714-30, 62856-724, 62856-724-05, 62856-724-30, 62856-720, 62856-720-05, 62856-720-30, 62856-718, 62856-718-05, 62856-718-30

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Lenvatinib pills and guides

What is Lenvatinib used for?

Lenvatinib is used for renal cell carcinoma and thyroid neoplasms.

Medicine type
Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label

Differentiated Thyroid Cancer

LENVIMA is indicated for the treatment of adult patients with locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer (DTC).

Renal Cell Carcinoma

LENVIMA, in combination with pembrolizumab, is indicated for the first-line treatment of adult patients with advanced renal cell carcinoma (RCC).

LENVIMA, in combination with everolimus, is indicated for the treatment of adult patients with advanced RCC following one prior anti-angiogenic therapy.

Hepatocellular Carcinoma

LENVIMA is indicated for the first-line treatment of patients with unresectable hepatocellular carcinoma (HCC).

Endometrial Carcinoma

LENVIMA, in combination with pembrolizumab, is indicated for the treatment of patients with advanced endometrial carcinoma (EC) that is mismatch repair proficient (pMMR) or not microsatellite instability-high (MSI-H), as determined by an FDA-approved test, who have disease progression following prior systemic therapy in any setting and are not candidates for curative surgery or radiation.

From the FDA-approved label on DailyMed (published Jun 30, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • Your pill shows E LENV 10 mg. The parts can be split between the two sides, so turn the pill over and check both.
  • It is red & yellow, capsule, 14 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold under the brand name Lenvima.

Ingredients

Active: Lenvatinib

Inactive: Calcium Carbonate, Hydroxypropyl Cellulose (90000 Wamw), Hydroxypropyl Cellulose, Low Substituted, Mannitol, Cellulose, Microcrystalline, Talc, Ferric Oxide Red, Ferric Oxide Yellow, Hypromelloses, Titanium Dioxide, Ferrosoferric Oxide, Potassium Hydroxide, Propylene Glycol, Shellac

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Lenvatinib pills